ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.

Zhenhua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.